Capricor Therapeutics (CAPR) Interest Coverage Ratio (2013 - 2017)

Capricor Therapeutics' Interest Coverage Ratio history runs 14 years deep, the most recent figure standing at 59.82 for Q1 2026.

• In Q1 2026, Interest Coverage Ratio rose 45.59% year-over-year to 59.82; the TTM figure through Mar 2026 stood at 290.8 (down 615.18% YoY), while the FY2025 annual figure was 0.39, up 7.03% from the prior year.
• Interest Coverage Ratio for Q1 2026 stood at 59.82, up from 117.82 in the prior quarter.
• The five-year high for Interest Coverage Ratio was 11.37 in Q4 2024, with the low at 254.82 in Q1 2023.
• The 5-year median for Interest Coverage Ratio is 1.02 (2024), against an average of 37.94.
• The sharpest annual moves came in 2024 and 2025: Interest Coverage Ratio soared 429.9% in 2024, then slumped 33136.24% in 2025.
• Capricor Therapeutics' Interest Coverage Ratio stood at 17.13 in 2022, then jumped by 112.53% to 2.15 in 2023, then jumped by 429.9% to 11.37 in 2024, then plunged by 1136.27% to 117.82 in 2025, then jumped by 49.22% to 59.82 in 2026.
• Business Quant data shows CAPR's Interest Coverage Ratio at 59.82 in Q1 2026, 117.82 in Q4 2025, and 0.79 in Q3 2025.